Search results for "arco"

showing 10 items of 1716 documents

Differentialdiagnose Berylliose/Sarkoidose bei einem Zahntechniker

2008

History and clinical findings Sarcoidosis was diagnosed in a dental technician when he was aged 21 years. Two years later prednisolone treatment was started and continued for 14 years because of nonproductive cough with progressive reduction in vital capacity and CO transfer capacity. Subsequently the risk of exposure to beryllium-containing dust in dental laboratories became known. In his case exposure had started before sarcoidosis had been diagnosed and had continued for 16 years. Changes typical of sarcoidosis (unproductive cough and dyspnoea; bihilar lymphadenopathy and reticulonodular marking in the chest radiogram) were now present, at the age of 40 years. Investigations Vital and di…

medicine.medical_specialtyTransfer capacityBerylliosisbusiness.industryNeopterinpeople.professionGeneral MedicineDental technicianmedicine.diseaseDermatologyrespiratory tract diseaseschemistry.chemical_compoundchemistrymedicinePrednisoloneSarcoidosisDifferential diagnosisUnproductive coughpeoplebusinessmedicine.drugDMW - Deutsche Medizinische Wochenschrift
researchProduct

Des lésions cutanées diffuses

2015

International audience

medicine.medical_specialty[ SDV.MHEP.GEG ] Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontologyNorwegian scabies030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineElderlyInternal MedicinemedicinePersonne âgéeImmunodepressionComputingMilieux_MISCELLANEOUS0303 health sciencesmedicine.diagnostic_test030306 microbiologybusiness.industry[SDV.MHEP.GEG]Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontologyGastroenterologymedicine.diseaseDermatologyGale norvégienneNorwegian scabiesPositron emission tomographySarcoidosisbusinessPanniculitis[ SDV.MHEP.DERM ] Life Sciences [q-bio]/Human health and pathology/Dermatology[SDV.MHEP.DERM]Life Sciences [q-bio]/Human health and pathology/Dermatology
researchProduct

Strength and muscle mass loss with aging process. Age and strength loss.

2014

Background aging process is associated with changes in muscle mass and strength with decline of muscle strength after the 30(th) life year. The aim of this study was to investigate these changes in muscle mass and strength. Patients & methods for this analysis 26 participants were subdivided in two groups. Group 1 comprises participants aged 40 years (n=12). We assessed anthropometrics, range of motions, leg circumferences and isometric strength values of the knee joints. Results besides comparable anthropometrics, circumferences and strength were higher in group 1 than in group 2. Circumference of upper leg (20 cm above knee articular space) showed for right leg a trend to a significant (m…

medicine.medical_specialtybusiness.industry030229 sport sciencesIsometric exerciseStrength lossAnthropometrymedicine.diseaseCircumferenceMuscle mass03 medical and health sciencesArticular space0302 clinical medicineQuartileSarcopeniaInternal medicinemedicineCardiologyOrthopedics and Sports MedicineOriginal Articlebusiness030217 neurology & neurosurgeryMuscles, ligaments and tendons journal
researchProduct

Pharmacological Management of Cancer Pain in the Elderly

2007

Existing studies indicate a high prevalence rate and poor management of cancer pain in the elderly. Pain is often considered an expected concomitant of aging, and older patients are considered more sensitive to opioids. Despite the well known pharmacokinetic changes in the elderly, the complex network of factors involved in the opioid response make the evaluation of a single element, such as age, more difficult. Notwithstanding such difficulties, appropriate analgesic treatment is able to control cancer pain in the elderly in most cases. Skills necessary to optimise pain control in older cancer patients include the ability to objectively assess functional age (not necessarily related to chr…

medicine.medical_specialtybusiness.industryAnalgesicChronic painPainCancerAnalgesics Non-Narcoticmedicine.diseaseAnalgesics OpioidPharmacotherapyQuality of lifeOpioidChemotherapy AdjuvantNeoplasmsmedicinePhysical therapyHumansPharmacology (medical)Geriatrics and GerontologyIntensive care medicineAdverse effectbusinessCancer painAgedmedicine.drugDrugs & Aging
researchProduct

Osteosarcoma of the Trapezium

2021

Osteogenic sarcoma is a malignant tumor that rarely affects the hand. When it does, it most often involves the phalanges or metacarpal heads. We present the case of a 51-year-old woman with a low-grade osteosarcoma affecting the trapezium bone of her left hand. A total trapeziectomy with partial removal of the first metatarsal, scaphoid, trapezoid, and capitate bones was performed, and no adjuvant therapy was administered. Six years after the intervention, the patient is disease-free, with excellent functionality and yearly imaging tests showing no signs of recurrence.

medicine.medical_specialtybusiness.industryFirst metatarsalPhalanxmedicine.diseaseSurgeryAdjuvant therapyMedicineOsteosarcomaOrthopedics and Sports MedicineSurgerySarcomabusinessTrapezium BoneThe Journal of Hand Surgery
researchProduct

Sezernierter Interleukin-2-Rezeptor als Aktivitätsparameter der Sarkoidose*

2008

Serum sIL-2-R levels were measured in 28 sarcoidosis patients at multiple time points before, during, and after therapy, with a mean follow-up time of 10.2 +/- 5.2 months, and the results compared with the clinical activity of the disease. Before therapy, 20 out of 24 episodes with active disease exhibited elevated levels of sIL-2-R (918 +/- 362 U/ml). In inactive disease after tapering off corticoid therapy the sIL-2-R levels were 453 +/- 274 U/ml. Disease activity under therapy also correlated with sIL-2-R serum levels. 23 out of 29 episodes with signs of activity under therapy had elevated sIL-2-R levels (808 +/- 409 U/ml). Only three of 28 patients in whom disease activity ceased after …

medicine.medical_specialtybusiness.industryGeneral MedicineDiseasemedicine.diseaseGastroenterologyfemale genital diseases and pregnancy complicationsDisease activityPulmonary sarcoidosisimmune system diseaseshemic and lymphatic diseasesInternal medicineActive diseaseMultiple timeMedicineSarcoidosisbusinessInactive diseaseReceptorDMW - Deutsche Medizinische Wochenschrift
researchProduct

Diagnose und Therapie der Sarkoidose

2000

medicine.medical_specialtybusiness.industryMEDLINEMedicineGeneral MedicineSarcoidosisbusinessIntensive care medicinemedicine.diseaseMedizinische Klinik
researchProduct

The future: critical knowledge about anti-itch therapy.

2005

:  Itch is an extremely frequent and enervating symptom of many diseases. Current anti-itch therapy, which is based almost exclusively on an “immunocentric” viewpoint, is often unsatisfactory. Recent studies show that this symptom is in fact the result of a complex interplay among skin, nervous system, endocrine system, and immune system. This explains the frequent failure of therapeutic strategies focused only on a single factor and suggests the usefulness of a polypharmacologic symptomatic treatment, designed on a case-by-case basis as a result of a multidisciplinary approach. We discuss the perspectives of anti-itch therapy in light of the new pathogenetic and pharmacologic acquisitions.

medicine.medical_specialtybusiness.industryNarcotic AntagonistsPruritusSymptomatic treatmentSingle factorDermatologyGeneral MedicineAntipruriticsMultidisciplinary approachImmunologyNeural PathwaysmedicineHumansDrug Therapy CombinationProtease InhibitorsCapsaicinIntensive care medicinebusinessDermatologic therapy
researchProduct

Body Mass Index and Cardiac Events in Elderly Patients

2009

Body Mass Index has been challenged as an anthropometric measurement in elderly patients. Recent data, even in elderly patients, has demonstrated that elevated body mass index affords a worse long-term prognosis, although the magnitude of this relationship weakens as one ages. Underweight patients, possibly due to elements of sarcopenia and/or frailty, are also at a higher risk of overall mortality. A number of inflammatory mediators may be responsible for such factors which likely contribute to the increased risk of cardiovascular events observed. Although body mass index has been implicated in the development of heart failure, coronary artery disease and mediates its effects through other…

medicine.medical_specialtybusiness.industryOverweightmedicine.diseaseBMI Obesity elderly cardiovascular riskCoronary artery diseaseHeart failureInternal medicineSarcopeniamedicineLean body massCardiologyUnderweightmedicine.symptombusinessBody mass indexObesity paradox
researchProduct

Physical exercise and sarcopenia in older people: position paper of the Italian Society of Orthopaedics and Medicine (OrtoMed)

2015

Sarcopenia is the age-associated loss of skeletal muscle mass and function. It is a major clinical problem for older people and research in understanding of pathogenesis, clinical consequences, management, and socioeconomic burden of this condition is growing exponentially. The causes of sarcopenia are multifactorial, including inflammation, insulin resistance, changing endocrine function, chronic diseases, nutritional deficiencies and low levels of physical activity. Operational definition of sarcopenia combines assessment of muscle mass, muscle strength and physical performance. The diagnosis of sarcopenia should be based on having a low appendicular fat free mass in combination with low …

medicine.medical_specialtybusiness.industrySettore MED/34 - Medicina Fisica E Riabilitativaphysical activityPhysical exercisemusculoskeletal systemmedicine.diseasesarcopeniaMalnutritionPhysical medicine and rehabilitationInsulin resistancephysical exerciseSarcopeniaPhysical therapymedicineLean body massPosition paperOriginal Articlemedicine.symptombusinesshuman activitiesBioelectrical impedance analysisWastingClinical Cases in Mineral and Bone Metabolism
researchProduct